Allmed Medical(SZ:002950) Sou Hu Cai Jing·2025-10-30 00:25Core Insights - The company reported a total revenue of 2.597 billion yuan for Q3 2025, with a net profit attributable to shareholders of 349 million yuan [1] - Operating cash flow was recorded at 551 million yuan [1] - The company's latest debt-to-asset ratio stands at 29.98%, ranking 76th among disclosed peers, with an increase of 1.50 percentage points from the previous quarter [1] - The gross profit margin is 29.95%, ranking 91st among disclosed peers [1] - Return on equity (ROE) is reported at 9.35% [1] - The diluted earnings per share (EPS) is 0.55 yuan [1] - Total asset turnover is 0.50 times, while inventory turnover is 2.73 times [1] - The number of shareholders is 37,800, with the top ten shareholders holding 419 million shares, accounting for 66.22% of the total share capital [1] Shareholder Information - The top ten shareholders and their respective holdings are as follows: - 崔金海: 23.0% - 程宏: 15.1% - 万小香: 9.87% - 陈浩华: 9.69% - 香港中央结算有限公司: 2.83% - 崔星炜: 2.36% - 崔辉: 2.36% - 刘君平: 0.42% - 大家人寿保险股份有限公司-分红产品: 0.29% - 招商银行股份有限公司-永赢中证全指医疗器械交易型开放式指数证券投资基金: 0.25% [1]